Division of Cancer Treatment and Diagnosis,
National Cancer Institute
9609 Medical Center Drive, Room 3W114
Bethesda, MD 20892
Phone (240) 276-5730
Fax (240) 276-7881
Steven F. Nothwehr, Ph.D. is a Program Director at the Translational Research Program within the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). Dr. Nothwehr manages Specialized Programs of Research Excellence (SPOREs) in Leukemia, Lymphoma and Myeloma.
His academic training included Ph.D. thesis work in Molecular Biology and Biochemistry at Washington University in St. Louis, in the laboratory of Dr. Jeffrey I. Gordon. After postdoctoral work at the University of Oregon, Dr. Nothwehr accepted an Assistant Professor position at the University of Missouri-Columbia, where he was later promoted to Associate Professor. There, he taught courses in -cell and molecular biology and performed research in the areas of intracellular protein/membrane trafficking and sorting and programmed cell death.
Dr. Nothwehr came to the NIH in 2007 as AAAS Science & Technology Policy Fellow where he rotated through positions at the National Institute of Arthritis and Musculoskeletal and Skin Diseases and at the NIH Office of the Director. He then took at position as a Scientific Review officer at the Center for Scientific Review where he managed the Cancer Genetics study section. He joined the Translational Research Program in 2011.